APOTHEEK REGHEERE: what changed
What changed
APOTHEEK REGHEERE
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€148,175
2024 · €136,059+€12,116
Equity
€2.7m
2024 · €3.2m-€469,622
Cash
€1.6m
2024 · €989,941+€634,243
Balance sheet total
€3.3m
2024 · €3.3m+€38,543
Largest movements
Assets
- Cash +€634,243
up €634,243 (+64.1%), from €989,941 to €1.6m
mainly Current investments (+€559,179) and Accrued charges and deferred income (+€481,072)
- Current investments -€559,179
down €559,179 (-44.7%), from €1.3m to €692,814
- Tangible fixed assets -€40,639
down €40,639 (-5.8%), from €696,193 to €655,554
of which Land and buildings: -€22,655
Equity and liabilities
- Accrued charges and deferred income +€481,072
new in 2025: €481,072
- Reserves -€469,622
down €469,622 (-14.9%), from €3.1m to €2.7m
of which Distributable reserves: -€469,622
Income statement
- Staff costs +€41,149
up €41,149 (+42.7%), from €96,436 to €137,584
- Gross operating margin +€41,123
up €41,123 (+12.7%), from €323,565 to €364,688
- Depreciation -€14,056
down €14,056 (-22.1%), from €63,632 to €49,576
- Taxes +€3,721
up €3,721 (+6.2%), from €60,256 to €63,977
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€136,059
Gross operating margin
+€41,123
Staff costs
-€41,149
Depreciation
+€14,056
Other operating charges
-€25
Financial income
+€2,733
Financial charges
-€900
Taxes
-€3,721
Result 2025
€148,175
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€700,790
Investment
+€551,249
Financing
-€617,796
Cash 2024
€989,941
From operations (derived)
+€700,790
Net result for the year
+€148,175
Depreciation
+€49,576
Stocks and contracts
-€3,301
Receivables within one year
-€153
Deferred charges and accrued income
-€1,672
Trade debts
+€23,815
Tax, wage and social debts
+€3,278
Accrued charges and deferred income
+€481,072
Investment (derived)
+€551,249
Investment in fixed assets (net)
-€7,930
Current investments
+€559,179
Financing
-€617,796
Contributions, distributions and other
-€617,796
Cash 2025
€1.6m
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,251,900 | €3,290,443 | +€38,543 | +1.2% |
| Fixed assets | 21/28 | €699,322 | €657,676 | -€41,646 | -6.0% |
| Intangible fixed assets | 21 | €3,129 | €2,122 | -€1,007 | -32.2% |
| Tangible fixed assets | 22/27 | €696,193 | €655,554 | -€40,639 | -5.8% |
| Land and buildings | 22 | €582,720 | €560,065 | -€22,655 | -3.9% |
| Plant, machinery and equipment | 23 | €110,711 | €92,563 | -€18,147 | -16.4% |
| Furniture and vehicles | 24 | €2,762 | €2,926 | +€163 | +5.9% |
| Current assets | 29/58 | €2,552,578 | €2,632,768 | +€80,189 | +3.1% |
| Stocks and contracts in progress | 3 | €157,600 | €160,901 | +€3,301 | +2.1% |
| Stocks | 30/36 | €157,600 | €160,901 | +€3,301 | +2.1% |
| Amounts receivable within one year | 40/41 | €145,411 | €145,564 | +€153 | +0.1% |
| Trade receivables | 40 | €128,965 | €139,440 | +€10,475 | +8.1% |
| Other amounts receivable | 41 | €16,445 | €6,124 | -€10,322 | -62.8% |
| Current investments | 50/53 | €1,251,994 | €692,814 | -€559,179 | -44.7% |
| Cash at bank and in hand | 54/58 | €989,941 | €1,624,184 | +€634,243 | +64.1% |
| Deferred charges and accrued income | 490/1 | €7,633 | €9,305 | +€1,672 | +21.9% |
| Total equity and liabilities | 10/49 | €3,251,900 | €3,290,443 | +€38,543 | +1.2% |
| Equity | 10/15 | €3,168,263 | €2,698,641 | -€469,622 | -14.8% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Reserves | 13 | €3,143,263 | €2,673,641 | -€469,622 | -14.9% |
| Tax-exempt reserves | 132 | €7,776 | €7,776 | = | 0.0% |
| Distributable reserves | 133 | €3,135,487 | €2,665,865 | -€469,622 | -15.0% |
| Amounts payable | 17/49 | €83,637 | €591,802 | +€508,165 | +608% |
| Amounts payable within one year | 42/48 | €83,637 | €110,731 | +€27,093 | +32.4% |
| Trade debts | 44 | €58,597 | €82,412 | +€23,815 | +40.6% |
| Suppliers | 440/4 | €58,597 | €82,412 | +€23,815 | +40.6% |
| Taxes, remuneration and social security | 45 | €25,040 | €28,319 | +€3,278 | +13.1% |
| Taxes | 450/3 | €12,933 | €10,910 | -€2,023 | -15.6% |
| Remuneration and social security | 454/9 | €12,107 | €17,408 | +€5,301 | +43.8% |
| Accrued charges and deferred income | 492/3 | - | €481,072 | +€481,072 | |
| Remuneration, social security and pensions | 62 | €96,436 | €137,584 | +€41,149 | +42.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €63,632 | €49,576 | -€14,056 | -22.1% |
| Other operating charges | 640/8 | €2,883 | €2,908 | +€25 | +0.9% |
| Gross operating margin | 9900 | €323,565 | €364,688 | +€41,123 | +12.7% |
| Operating profit (loss) | 9901 | €160,616 | €174,620 | +€14,005 | +8.7% |
| Financial income | 75/76B | €36,529 | €39,262 | +€2,733 | +7.5% |
| Recurring financial income | 75 | €36,529 | €39,262 | +€2,733 | +7.5% |
| Financial charges | 65/66B | €830 | €1,730 | +€900 | +108% |
| Recurring financial charges | 65 | €830 | €1,730 | +€900 | +108% |
| Profit (loss) for the period before taxes | 9903 | €196,315 | €212,152 | +€15,837 | +8.1% |
| Income taxes | 67/77 | €60,256 | €63,977 | +€3,721 | +6.2% |
| Profit (loss) for the period | 9904 | €136,059 | €148,175 | +€12,116 | +8.9% |
| Profit (loss) for the period to be appropriated | 9905 | €136,059 | €148,175 | +€12,116 | +8.9% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.